Showing results (71-80 of 718) with videos related to
Sort By:
Pageof 72
Pulmonary Pharmacology & Therapeutics|April 9, 2017
Role of dual bronchodilators in COPD: A review of the current evidence for indacaterol/glycopyrroniumJoachim H Ficker, Klaus F Rabe, Tobias WelteHealth Policy (Amsterdam, Netherlands)|August 25, 2016
Costs and outcomes of the German disease management programme (DMP) for chronic obstructive pulmonary disease (COPD)-A large population-based cohort studyDmitrij Achelrod, Tobias Welte, Jonas Schreyögg, et al.Deutsches Arzteblatt International|April 23, 2024
Respiratory Syncytial Virus-Associated Respiratory Diseases in Children and AdultsTobias Tenenbaum, Johannes Liese, Tobias Welte, et al.Deutsches Arzteblatt International|January 19, 2017
The Differential Diagnosis of DyspneaDominik Berliner, Nils Schneider, Tobias Welte, et al.Current Opinion in Critical Care|July 24, 2012
The lung transplant patient in the ICUThomas Fuehner, Mark Greer, Tobias Welte, et al.The Lancet. Infectious Diseases|March 26, 2010
Rethinking the concepts of community-acquired and health-care-associated pneumoniaSantiago Ewig, Tobias Welte, Jean Chastre, et al.BMC Pulmonary Medicine|January 28, 2015
Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD--the ABACOPD studyGernot G U Rohde, Armin Koch, Tobias Welte, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|September 6, 2023
The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virusSusanne Simon, Oana Joean, Tobias Welte, et al.Respiratory Physiology & Neurobiology|October 11, 2014
The role of BIM-EL and BCL2-α on the efficacy of erlotinib and gefitinib in lung cancerJacinta Simasi, Christopher Oelkrug, Andreas Schubert, et al.Current Drug Targets|June 22, 2006
Nanoparticle-based diagnosis and therapyDavid A Groneberg, Michael Giersig, Tobias Welte, et al.Pageof 72